{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE335nnn/GSE335697/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"species":["Homo sapiens"],"gds_type":["Non-coding RNA profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE335697"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"miRNA expression profiling of fulvestrant-treated MCF7 breast cancer cells","description":"Fulvestrant is a selective estrogen receptor degrader used for the treatment of hormone receptor-positive breast cancer. In this study, miRNA expression changes in response to fulvestrant exposure were analyzed in MCF7 breast cancer cells. MCF7 cells were selected because they are a luminal-type breast cancer cell line and are relevant to fulvestrant therapy.","dates":{"publication":"2026/08/19"},"accession":"GSE335697","cross_references":{"GSM":["GSM9817777","GSM9817776","GSM9817775","GSM9817774"],"GPL":["18573"],"GSE":["335697"],"taxon":["Homo sapiens"],"PMID":["[42589442]"]}}